YouTube video by Marcelle Pick arguing that the rising promotion of GLP-1 weight-loss drugs (e.g., Ozempic, Wegovy) is driven by financial interests of the food and pharmaceutical industries; the speaker claims 93% of Americans have metabolic dysfunction largely caused by poor diet and lifestyle and links processed-food profits to drug sales.
93% (claimed by the speaker).
And are we really dealing with an Ozempic or wegovy deficiency? But why the push for these drugs? So what I would say is we need to follow the money trail. And you'll find yourself in the clutches, as I've mentioned before, of the food industry and the pharmaceutical industry as well. And these are giants, if you think about it. So consider this. 93% of Americans suffer from some form of metabolic dysfunction. That's 93%. And it's generally due to poor diet and lifestyle, not genetics. And that's the same industry responsible for manufacturing, remember this? Processed addictive foods, and they're profiting from the sale of these weight loss drugs like Ozempic.
